Skip to main content
glpverdict
Subscribe⊙Sign in
🔍12+ medical reviewers in network🏆FDA & peer-reviewed sources📈Updated weekly🩺Medically reviewed content

Newsletter

Weekly GLP-1 updates, no filler

Shortages, savings, new approvals, and reviewer-vetted guidance. 5 min/week.

Free Week-1 Survival Kit PDF on signup· 5,400+ readers · weekly · unsubscribe anytime

glpverdict

Evidence-based GLP-1 reviews. Medically reviewed, affiliate-funded, editorially independent.

Language

EnglishEspañol

Compare providers

  • Best overall
  • Cheapest
  • Best rated
  • Accepts insurance
  • Most medications
  • Side-by-side

Medications

  • Wegovy
  • Ozempic
  • Zepbound
  • Mounjaro
  • Saxenda
  • Rybelsus
  • All medications

Tools

  • Match me to a provider
  • Eligibility checker
  • Weight-loss projection
  • PAP eligibility
  • Symptom triage
  • Insurance coverage
  • All tools

Coverage & savings

  • Insurance appeals
  • GLP-1 cost by state
  • Cost trends
  • Compounded vs brand
  • Switching guides
  • Shortage tracker
  • Drug pipeline

Research & editorial

  • Primary-data research
  • GLP-1 Diaries
  • News + recalls
  • Lawsuit + MDL tracker
  • Q&A library
  • Glossary
  • Editorial board
  • Editorial standards
  • Press kit

GLP-1 by audience

  • Sleep
  • Fitness
  • Mental health
  • Pediatric
  • Veterans
  • Medicare
  • Seniors
  • Men
  • Postmenopausal
  • Trans + gender-diverse
  • Post-bariatric

For informational purposes only. Not medical advice. Talk to a licensed clinician before starting, stopping, or switching medication. © 2026 Glpverdict.

  • Medically reviewed
  • FDA + peer-reviewed
  • Updated weekly
  • Independent ranking
HomeTop picksMedsQuizSaved
HomeProvidersFound

Provider review

Found

Personalized weight-loss program offering GLP-1s plus non-GLP-1 alternatives.

Dr. Jane Novak — medical reviewer headshotMedically reviewed by Dr. Jane Novak, MD, MPH 6 min readUpdated May 24, 2026

In this article

  • Pricing & coverage
  • Pros & cons
  • Reader reviews

Key takeaways

  • Found is cash-pay only, starting at $99.00/month.
  • Operates in 50 states, prescribes 1 GLP-1 medication.
  • Editorial rating: 3.9/5, medically reviewed by Dr. Jane Novak.
  • Prescribes brand-name FDA-approved GLP-1 medications via licensed clinicians.
  • 3.90/5 rating
  • From $99.00/mo
  • 50 states
  • 1 GLP-1
Medically reviewed by Dr. Jane Novak, MD, MPH on May 24, 2026
Found provider review
Found is a GLP-1 telehealth provider operating in 50 U.S. states.Photo: Unsplash
From
$99/mo
Medications
1
States
50
Rating
3.9/5
Visit Found Compare alternatives

We earn a commission if you sign up through this link. Editorial ranking is independent.

What we liked

  • Personalized intake quiz
  • Non-GLP-1 alternatives if disqualified

What gave us pause

  • Slower onboarding than competitors
  • Less price transparency

Medical review

Reviewed by Dr. Jane Novak, MD, MPH

Dr. Jane Novak is a board-certified internist and clinical researcher with 14 years of experience focused on metabolic health, pharmacotherapy, and obesity medicine. She practices at UCSF Health in Oakland, California, where she co-directs the GLP-1 prescribing clinic, and serves as a clinical assistant professor at UCSF School of Medicine. Her published work on long-term GLP-1 retention and prior-authorization barriers has appeared in JAMA, NEJM Catalyst, and Obesity Reviews. Dr. Novak is a Diplomate of the American Board of Obesity Medicine and a member of the Obesity Society, ENDO, and the American College of Physicians. On Health Portal she reviews every medication overview and clinical-guidance page for FDA-label accuracy, dosing fidelity, and contraindication coverage before publication.

View profile

Reader reviews

Verified user experiences. Reviews are moderated before publishing — we strip personal info and reject spam.

No user reviews yet

Be the first to share your experience — consults, shipping, billing, support. The form below takes ~2 minutes.

Share your experience with Found

Reviews are moderated before publishing. We do not display your email.

Your rating

By submitting, you agree we may publish the rating, title, body, and your name (if provided). Your email is private and used only for verification.

Price drop alert

Get an email the moment this provider's monthly cost drops below your threshold. One email per threshold crossing — no marketing spam.

Ready to try Found?

From $99.00/mo. Commission-funded, editorially independent.

Get started with Found
How to get started with FoundStart a Found consultation

Medically reviewed by

Portrait of Dr. Jane Novak
Dr. Jane Novak

MD, MPH

Dr. Jane Novak is a board-certified internist and clinical researcher with 14 years of experience focused on metabolic health, pharmacotherapy, and obesity medicine. She practices at UCSF Health in Oakland, California, where she co-directs the GLP-1 prescribing clinic, and serves as a clinical assistant professor at UCSF School of Medicine. Her published work on long-term GLP-1 retention and prior-authorization barriers has appeared in JAMA, NEJM Catalyst, and Obesity Reviews. Dr. Novak is a Diplomate of the American Board of Obesity Medicine and a member of the Obesity Society, ENDO, and the American College of Physicians. On Health Portal she reviews every medication overview and clinical-guidance page for FDA-label accuracy, dosing fidelity, and contraindication coverage before publication.

See full profile Last reviewed May 24, 2026
People also ask

Common questions readers ask

How much does Wegovy cost without insurance?
List price runs ~$1,350/mo at retail. NovoCare Pharmacy cash-pay direct from Novo Nordisk is $499/mo for all dose strengths. The Wegovy Savings Offer caps copay at $0-$225/mo for commercially insured patients depending on coverage status (not a flat $225 for everyone).
Full evidence-graded answer
Does insurance cover Zepbound?
Most commercial insurance plans cover Zepbound with prior authorization for adults with BMI ≥30 (or ≥27 + a weight-related comorbidity). Medicare Part D excludes anti-obesity drugs by federal law, so Medicare patients pay cash unless they qualify for Lilly Cares.
Full evidence-graded answer
Is Ozempic the same as Wegovy?
Same active molecule (semaglutide), different FDA indications and maximum doses. Ozempic = type 2 diabetes, max 2 mg/week. Wegovy = chronic weight management, max 2.4 mg/week. Insurance pathways are very different.
Full evidence-graded answer
Can I still get compounded GLP-1 in 2026?
For semaglutide: no — FDA declared the shortage resolved February 21, 2025 and 503A compounding is no longer broadly permitted. For tirzepatide: shortage resolved October 2024 (re-affirmed December 2024), with a wind-down enforcement window that ended in 2025. Some clinics still market "compounded" formulations with added ingredients (B12, glycine) as personalized prescriptions; the legal status is contested.
Full evidence-graded answer
How does Wegovy compare to Saxenda?
Both are GLP-1 agonists from Novo Nordisk. Wegovy (semaglutide, weekly) produces ~15% mean weight loss; Saxenda (liraglutide, daily) produces ~6-8%. Wegovy is also cheaper per kg-lost, more convenient, and has cardiovascular outcome data (SELECT trial). Saxenda was first approved for adolescents (2020); Wegovy followed in 2022 — both are available for ages 12-17.
Full evidence-graded answer

Was this page helpful?

Visit Found